Cargando…

Comprehensive Analysis of RAPGEF2 for Predicting Prognosis and Immunotherapy Response in Patients with Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is the sixth most common tumor worldwide. Additionally, deletion of RAPGEF2 plays a critical role in CNV and related to tumor immune microenvironment, whereas the prognostic potential of RAPGEF2 in HCC patient needs to be explored. METHODS: We looked for pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Qing, Hu, Yangzhi, Ma, Qinghui, Yang, Shanglin, Chen, Junpeng, Wen, Shunqian, Liao, Guanqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064514/ https://www.ncbi.nlm.nih.gov/pubmed/35518785 http://dx.doi.org/10.1155/2022/6560154

Ejemplares similares

Cascade Amplification of Pyroptosis and Apoptosis for Cancer Therapy through a Black Phosphorous-Doped Thermosensitive Hydrogel
por: Wu, Qing, et al.
Publicado: (2023)

Harmonic Scalpel versus Monopolar Electrocauterization in Cholecystectomy
por: Liao, Guanqun, et al.
Publicado: (2016)

Comprehensive behavioral analysis of mice deficient in Rapgef2 and Rapgef6, a subfamily of guanine nucleotide exchange factors for Rap small GTPases possessing the Ras/Rap-associating domain
por: Maeta, Kazuhiro, et al.
Publicado: (2018)

Comprehensive analysis of anoikis‐related lncRNAs for predicting prognosis and response of immunotherapy in hepatocellular carcinoma
por: Du, Sihao, et al.
Publicado: (2023)

DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma
por: Chen, Yunfei, et al.
Publicado: (2021)

Overexpression of RAPGEF3 enhances the therapeutic effect of dezocine in treatment of neuropathic pain
por: Liu, Xue, et al.
Publicado: (2021)

NCS-Rapgef2, the Protein Product of the Neuronal Rapgef2 Gene, Is a Specific Activator of D1 Dopamine Receptor-Dependent ERK Phosphorylation in Mouse Brain
por: Jiang, Sunny Zhihong, et al.
Publicado: (2017)

Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy
por: Yu, Lihua, et al.
Publicado: (2022)

Increased microvascular permeability in mice lacking Epac1 (Rapgef3)
por: Kopperud, R. K., et al.
Publicado: (2016)

A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma
por: Fu, Xing, et al.
Publicado: (2022)

Aging-related features predict prognosis and immunotherapy efficacy in hepatocellular carcinoma
por: Hong, Ting, et al.
Publicado: (2022)

Identification of cancer-associated fibroblasts signature for predicting the prognosis and immunotherapy response in hepatocellular carcinoma
por: Ye, Jianzhong, et al.
Publicado: (2023)

Comprehensive Analysis of Cellular Senescence-Related Genes in Prognosis, Molecular Characterization and Immunotherapy of Hepatocellular Carcinoma
por: Sun, Liang, et al.
Publicado: (2022)

Membranes prime the RapGEF EPAC1 to transduce cAMP signaling
por: Sartre, Candice, et al.
Publicado: (2023)

PTEN-related risk classification models for predicting prognosis and immunotherapy response of hepatocellular carcinoma
por: Cao, Lu, et al.
Publicado: (2023)

Comprehensive analysis of PHGDH for predicting prognosis and immunotherapy response in patients with endometrial carcinoma
por: Zhang, He, et al.
Publicado: (2023)

Comprehensive analysis and validation of SNX7 as a novel biomarker for the diagnosis, prognosis, and prediction of chemotherapy and immunotherapy response in hepatocellular carcinoma
por: Chen, Jianlin, et al.
Publicado: (2023)

ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Fahui, et al.
Publicado: (2022)

ELOVLs Predict Distinct Prognosis Value and Immunotherapy Efficacy In Patients With Hepatocellular Carcinoma
por: Zhang, Yu, et al.
Publicado: (2022)

Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma
por: Hu, Yinan, et al.
Publicado: (2022)

Autophagy-related genes prognosis signature as potential predictive markers for immunotherapy in hepatocellular carcinoma
por: Mao, Deli, et al.
Publicado: (2020)

Identification of the Immune Cell Infiltration Landscape in Hepatocellular Carcinoma to Predict Prognosis and Guide Immunotherapy
por: Yang, Shiyan, et al.
Publicado: (2021)

A Lamin Family-Based Signature Predicts Prognosis and Immunotherapy Response in Hepatocellular Carcinoma
por: Yang, Yongyu, et al.
Publicado: (2022)

Circulating immune index predicting the prognosis of patients with hepatocellular carcinoma treated with lenvatinib and immunotherapy
por: Guo, De-Zhen, et al.
Publicado: (2023)

Deletion of Rapgef6, a candidate schizophrenia susceptibility gene, disrupts amygdala function in mice
por: Levy, R J, et al.
Publicado: (2015)

A RAPGEF6 variant constitutes a major risk factor for laryngeal paralysis in dogs
por: Hadji Rasouliha, Sheida, et al.
Publicado: (2019)

Circ-RAPGEF5 promotes intrahepatic cholangiocarcinoma progression by stabilizing SAE1 to facilitate SUMOylation
por: Zheng, Junhao, et al.
Publicado: (2023)

MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p
por: Liao, Guanqun, et al.
Publicado: (2019)

Crucial Role of Rapgef2 and Rapgef6, a Family of Guanine Nucleotide Exchange Factors for Rap1 Small GTPase, in Formation of Apical Surface Adherens Junctions and Neural Progenitor Development in the Mouse Cerebral Cortex123
por: Maeta, Kazuhiro, et al.
Publicado: (2016)

Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma
por: Wang, Qingbin, et al.
Publicado: (2023)

Comprehensive Analyses of MELK-Associated ceRNA Networks Reveal a Potential Biomarker for Predicting Poor Prognosis and Immunotherapy Efficacy in Hepatocellular Carcinoma
por: Liu, Yu, et al.
Publicado: (2022)

Identification of cell senescence molecular subtypes in prediction of the prognosis and immunotherapy of hepatitis B virus-related hepatocellular carcinoma
por: Yu, Xue, et al.
Publicado: (2022)

A novel pyroptosis-regulated gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma
por: Zhang, Baozhu, et al.
Publicado: (2022)

An inflammation-related gene landscape predicts prognosis and response to immunotherapy in virus-associated hepatocellular carcinoma
por: Gao, Ying-jie, et al.
Publicado: (2023)

Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients
por: Qiu, Jun, et al.
Publicado: (2023)

Cdk5-mediated phosphorylation of RapGEF2 controls neuronal migration in the developing cerebral cortex
por: Ye, Tao, et al.
Publicado: (2014)

Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma
por: Liu, Furong, et al.
Publicado: (2020)

Comprehensive Analysis of the Expression and Prognosis for Lipid Metabolism-Related Genes in Hepatocellular Carcinoma
por: Fan, Wen-Jie, et al.
Publicado: (2022)

Analysis of the Heterogeneity of the Tumor Microenvironment and the Prognosis and Immunotherapy Response of Different Immune Subtypes in Hepatocellular Carcinoma
por: Hu, Jian, et al.
Publicado: (2022)

Development and Validation of Genome Instability-Associated lncRNAs to Predict Prognosis and Immunotherapy of Patients With Hepatocellular Carcinoma
por: Yan, Yifeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_imqdail7iok1fqvc1g9mdire3q